Hemagen Diagnostics (HMGN) 8-K Current report

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported):                                                                                         February 13, 2004

                                            HEMAGEN DIAGNOSTICS, INC.                                             
(Exact name of registrant as specified in its charter)

Delaware	1-11700	04-2869857
(State or other jurisdiction of incorporation)	(Commission File No.)	(IRS Employer Identification No.)

                                                  9033 Red Branch Road, Columbia, Maryland 21045                                                   
(Address of principal executive offices) (Zip Code)

                                                                                     (410) 740-3198                                                                                    
(Registrant’s telephone number, including area code)

Item 12.    Results of Operations and Financial Condition.

                 On February 13, 2004, the Registrant issued the press release attached as Exhibit 99. The Registrant included information illustrating the effect of non-cash earnings charges on earnings because of the magnitude of those items.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 13, 2004 HEMAGEN DIAGNOSTICS, INC.


By: /s/Deborah F. Ricci
      ——————————————
      Deborah F. Ricci
      Chief Financial Officer
      (Principal Accounting Officer)